ReviewClinical pharmacology : advances and applications2025

Metabolomics Insights into the Benefits of SGLT2 Inhibitors in Type 2 Diabetes.

Artemis Kyriakidou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.